William Looney
Editor-in-Chief
wlooney@advanstar.com
William Looney is the Editor in Chief of Pharmaceutical Executive magazine, a monthly print and weekly on-line publication focused on the “c suite” concerns of senior managers in the biopharmaceutical industry. In addition to editorial content, he is responsible for supporting the magazine through related educational media activities and serving as a thought leader in contacts between the magazine and a wide variety of organizations.
Prior to joining Pharmaceutical Executive in August 2009, Mr. Looney served for 11 years as Senior Director at Pfizer, Inc. where he managed the company’s public policy issue development, positioning and advocacy activities outside the US. In that capacity, he worked closely with the academic and think tank community, coordinated Pfizer CEO relationships with the World Economic Forum, Japan’s Nikkei Management Forum and other policy groups, and chaired committees of key biopharma trade associations, including PhRMA and the IFPMA.
Earlier in his career, he served as an internal communications manager and speech writer at Warner Lambert Company in both the US and in Europe. He also was senior editor for the Economist Intelligent Unit, where he was responsible for consumer issues and management practices in Europe.
He has also been a consultant to the organization for Economic Cooperation and Development [OECD], and is the author of numerous research papers and studies focused on the relationships between product and process innovation and public health.
In March 2011 he was honored by American Business Media with a Neal Award for 'Best Commentary' for his monthly 'From the Editor' columns.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.